Silibinin: a novel inhibitor of Aβ aggregation.


Alzheimer's disease (AD) is characterized by the abnormal aggregation of amyloid β peptide (Aβ) into extracellular fibrillar deposits known as amyloid plaque. Inhibition of Aβ aggregation is therefore viewed as a potential method to halt or slow the progression of AD. It is reported that silibinin (silybin), a flavonoid derived from the herb milk thistle… (More)
DOI: 10.1016/j.neuint.2010.12.017


Cite this paper

@article{Yin2011SilibininAN, title={Silibinin: a novel inhibitor of Aβ aggregation.}, author={Fei Yin and Jianhui Liu and Xiuhong Ji and Yanwen Wang and Jeffrey A Zidichouski and Junzeng Zhang}, journal={Neurochemistry international}, year={2011}, volume={58 3}, pages={399-403} }